Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease - Cobleigh,M.A.; Vogel,C.L.; Tripathy,D. (J Clin Oncol, 1999)